Diabetes Kongress 2023
Kalender Liste Personen Favoriten
zur Liste
Dr. Nina Schwering
Lilly Deutschland GmbH Germany
  • Vortrag Cardiovascular effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists or liraglutide in the EMPRISE study Speaker
    Datum: 19.05.2023 , Zeit: 11:05 | Thema: Poster
    Details